SK54599A3 - Composition for the treatment of asthma, containing loratadine and a decongestant - Google Patents

Composition for the treatment of asthma, containing loratadine and a decongestant Download PDF

Info

Publication number
SK54599A3
SK54599A3 SK545-99A SK54599A SK54599A3 SK 54599 A3 SK54599 A3 SK 54599A3 SK 54599 A SK54599 A SK 54599A SK 54599 A3 SK54599 A3 SK 54599A3
Authority
SK
Slovakia
Prior art keywords
loratadine
pseudoephedrine
asthma
administered
use according
Prior art date
Application number
SK545-99A
Other languages
English (en)
Slovak (sk)
Inventor
Alan G Harris
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of SK54599A3 publication Critical patent/SK54599A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK545-99A 1996-10-31 1997-10-29 Composition for the treatment of asthma, containing loratadine and a decongestant SK54599A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73966996A 1996-10-31 1996-10-31
PCT/US1997/019158 WO1998018470A1 (en) 1996-10-31 1997-10-29 Composition, for the treatment of asthma, containing loratadine and a decongestant

Publications (1)

Publication Number Publication Date
SK54599A3 true SK54599A3 (en) 2000-08-14

Family

ID=24973307

Family Applications (1)

Application Number Title Priority Date Filing Date
SK545-99A SK54599A3 (en) 1996-10-31 1997-10-29 Composition for the treatment of asthma, containing loratadine and a decongestant

Country Status (21)

Country Link
EP (1) EP0941091A1 (cs)
JP (1) JP2000505104A (cs)
KR (1) KR20000052922A (cs)
CN (1) CN1235545A (cs)
AR (1) AR008908A1 (cs)
AU (1) AU731756B2 (cs)
BR (1) BR9712705A (cs)
CA (1) CA2268546A1 (cs)
CO (1) CO4910128A1 (cs)
CZ (1) CZ150999A3 (cs)
HU (1) HUP9904075A3 (cs)
ID (1) ID23431A (cs)
IL (1) IL129662A0 (cs)
NO (1) NO992062L (cs)
NZ (1) NZ335078A (cs)
PE (1) PE11399A1 (cs)
PL (1) PL333056A1 (cs)
SK (1) SK54599A3 (cs)
TR (1) TR199901003T2 (cs)
WO (1) WO1998018470A1 (cs)
ZA (1) ZA979731B (cs)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1032392A4 (en) * 1997-10-29 2001-05-09 J Med Pharmaceuticals Inc RHINITIS TREATMENT BY ANTIHISTAMINE / DECONGESTIVUM ADMINISTRATION
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
AU6018899A (en) * 1998-09-10 2000-04-03 Schering Corporation Antihistamines for treating non-infective sinusitis or otitis media
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
KR100505899B1 (ko) * 1999-02-23 2005-08-01 주식회사유한양행 로라타딘과 슈도에페드린을 함유한 캅셀제 조성물
CN1161112C (zh) * 1999-02-23 2004-08-11 株式会社柳韩洋行 含氯雷他定和伪麻黄碱的药物胶囊组合物
WO2000057880A1 (en) * 1999-03-29 2000-10-05 Schering Corporation Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine
WO2001045668A2 (en) * 1999-12-20 2001-06-28 Schering Corporation Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
SK287105B6 (sk) * 1999-12-20 2009-12-07 Schering Corporation Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním
EP1276502A1 (en) * 2000-04-14 2003-01-22 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
AU2001264806A1 (en) * 2000-05-25 2001-12-03 Schering Corporation Stable liquid and solid formulations
WO2003000264A1 (en) * 2001-06-20 2003-01-03 Schering Corporation Antihistamines for the treatment of nasal congestion and nasal obstruction
CA2612179C (en) 2005-06-17 2016-08-02 Aft Pharmaceuticals Limited A pharmaceutical composition comprising loratadine and its use to treat patients with upper respiratory mucosal congestion
JP5175278B2 (ja) * 2006-06-01 2013-04-03 エムエスディー コンシューマー ケア， インコーポレイテッド 結腸吸収のためのフェニレフリン薬学的製剤および組成物
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
KR101540191B1 (ko) * 2014-02-24 2015-07-28 성균관대학교산학협력단 로라타딘을 포함하는 항염증용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1110397A (en) * 1964-10-02 1968-04-18 Mead Johnson & Co Ephedrine composition
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

Also Published As

Publication number Publication date
ID23431A (id) 2000-04-20
CN1235545A (zh) 1999-11-17
WO1998018470A1 (en) 1998-05-07
HUP9904075A2 (hu) 2000-05-28
IL129662A0 (en) 2000-02-29
KR20000052922A (ko) 2000-08-25
PL333056A1 (en) 1999-11-08
ZA979731B (en) 1998-04-29
NZ335078A (en) 2000-10-27
JP2000505104A (ja) 2000-04-25
EP0941091A1 (en) 1999-09-15
CO4910128A1 (es) 2000-04-24
TR199901003T2 (xx) 1999-07-21
AU4995397A (en) 1998-05-22
AR008908A1 (es) 2000-02-23
NO992062D0 (no) 1999-04-29
PE11399A1 (es) 1999-02-09
HUP9904075A3 (en) 2002-02-28
NO992062L (no) 1999-04-29
AU731756B2 (en) 2001-04-05
BR9712705A (pt) 1999-10-26
CZ150999A3 (cs) 1999-10-13
CA2268546A1 (en) 1998-05-07

Similar Documents

Publication Publication Date Title
SK54599A3 (en) Composition for the treatment of asthma, containing loratadine and a decongestant
US20060276495A1 (en) Treatment methods of nasal congestion and nasal obstruction
Aaronson Evaluation of cetirizine in patients with allergic rhinitis and perennial asthma
Bousquet et al. A 12‐week, placebo‐controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitis
JP2022003100A (ja) 神経学的及び神経変性疾患及び障害を処置するための鼻腔投与組成物
US6432972B2 (en) Treating allergic and inflammatory conditions
KR101071798B1 (ko) 로플루미래스트와 포르모테롤을 포함하는 신규한상승작용성 조합물
KR20180033201A (ko) 진해 조성물 및 방법
JP2003048834A (ja) 医薬組成物
WO2008085392A1 (en) Methods for treating nasal congestion in hepatically impaired patients
AU2001247867B2 (en) Composition for treating allergic and inflammatory conditions with cough containing a non-sedating histamine and an expectorant
JP2004534820A (ja) 鼻うっ血および鼻閉塞の処置のための抗ヒスタミン薬
MXPA99003936A (en) Composition, for the treatment of asthma, containing loratadine and a decongestant
WO2002047689A2 (en) Use of cetirizine or efletirizine for preventing urticaria
JP2003509458A (ja) アレルギー状態および炎症状態の処置
AU2001247867A1 (en) Composition for treating allergic and inflammatory conditions with cough containing a non-sedating histamine and an expectorant
Maesen et al. Protective effect by UCB JO28 against histamine and methacholine induced bronchial hyperreactivity
AU2002315357A1 (en) Antihistamines for the treatment of nasal congestion and nasal obstruction
AU2006201218A1 (en) Treating allergic and inflammatory conditions